(1S,2R)-1-(2-NAPHTHYL)-2-[(S)-1-HYDROXYPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
Compound with spectra: 1 NMR
![(1S,2R)-1-(2-NAPHTHYL)-2-[(S)-1-HYDROXYPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE](/api/compound/IMlOezwEpLp.png?ph=true&h=300&w=458 "(1S,2R)-1-(2-NAPHTHYL)-2-[(S)-1-HYDROXYPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE")
| SpectraBase Compound ID | IMlOezwEpLp |
|---|---|
| InChI | InChI=1S/C21H27NO2/c1-4-19(23)18-14-21(18,20(24)22(5-2)6-3)17-12-11-15-9-7-8-10-16(15)13-17/h7-13,18-19,23H,4-6,14H2,1-3H3/t18-,19-,21+/m0/s1 |
| InChIKey | HYCIROWFHDOLTO-IRFCIJBXSA-N |
| Mol Weight | 325.45 g/mol |
| Molecular Formula | C21H27NO2 |
| Exact Mass | 325.204179 g/mol |
| Enantiomer InChIKey | HYCIROWFHDOLTO-SBHAEUEKSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(1S,2R)-1-(2-NAPHTHYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
(1S,4S,5R)-2-OXO-4-ETHYL-1-(2-NAPHTHYL)-3-OXABICYCLO-[3.1.0]-HEXANE
(1S,2R)-1-(2-FLUOROPHENYL)-2-[(S)-1-HYDROXYPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-(2-METHYLPHENYL)-2-[(S)-1-HYDROXYPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-(3-METHYLPHENYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-(3-FLUOROPHENYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-(2-FLUOROPHENYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
(1S,2R)-1-(2-METHYLPHENYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
Tri(2-azulenyl)-1-methylazetidin-2-one
(1S,2R)-1-(1-NAPHTHYL)-2-FORMYL-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of derivatives of (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) modified at the 1-aromatic moiety as novel NMDA receptor antagonists: the aromatic group is essential for the activity | Bioorganic & Medicinal Chemistry | 2002 |